End-of-day quote
Shenzhen S.E.
23:00:00 29/04/2024 BST
|
5-day change
|
1st Jan Change
|
7.01
CNY
|
-1.27%
|
|
-.--%
|
-3.97%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
19,664
|
66,460
|
56,810
|
35,857
|
31,176
|
29,938
|
-
|
Enterprise Value (EV)
1 |
19,664
|
66,460
|
54,335
|
35,857
|
31,176
|
29,938
|
29,938
|
P/E ratio
|
89.1
x
|
66.4
x
|
50.5
x
|
71.8
x
|
459
x
|
14
x
|
19.1
x
|
Yield
|
-
|
0.6%
|
1.45%
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
12
x
|
19.9
x
|
16.2
x
|
-
|
12.9
x
|
9.28
x
|
7.78
x
|
EV / Revenue
|
12
x
|
19.9
x
|
16.2
x
|
-
|
12.9
x
|
9.28
x
|
7.78
x
|
EV / EBITDA
|
62,338,247
x
|
-
|
43,748,464
x
|
-
|
-
|
-
|
-
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
5.57
x
|
15.3
x
|
7.53
x
|
-
|
4.59
x
|
4.27
x
|
4.12
x
|
Nbr of stocks (in thousands)
|
4,056,045
|
4,056,045
|
4,270,740
|
4,237,631
|
4,270,736
|
4,270,736
|
-
|
Reference price
2 |
4.848
|
16.39
|
13.30
|
8.462
|
7.300
|
7.010
|
7.010
|
Announcement Date
|
07/04/20
|
26/02/21
|
07/04/22
|
19/04/23
|
15/04/24
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
1,638
|
3,334
|
3,500
|
-
|
2,415
|
3,225
|
3,850
|
EBITDA
|
315.4
|
-
|
1,299
|
-
|
-
|
-
|
-
|
EBIT
1 |
209.7
|
1,065
|
1,165
|
-
|
123
|
586
|
762
|
Operating Margin
|
12.8%
|
31.96%
|
33.28%
|
-
|
5.09%
|
18.17%
|
19.79%
|
Earnings before Tax (EBT)
1 |
207.2
|
1,057
|
1,157
|
-
|
121.5
|
585
|
761
|
Net income
1 |
220.6
|
1,001
|
1,111
|
502
|
67.7
|
1,647
|
1,351
|
Net margin
|
13.47%
|
30.02%
|
31.74%
|
-
|
2.8%
|
51.06%
|
35.1%
|
EPS
2 |
0.0544
|
0.2467
|
0.2633
|
0.1178
|
0.0159
|
0.5000
|
0.3667
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
0.0981
|
0.1923
|
-
|
-
|
-
|
-
|
Announcement Date
|
07/04/20
|
26/02/21
|
07/04/22
|
19/04/23
|
15/04/24
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
2,475
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
6.43%
|
25.5%
|
17.5%
|
-
|
0.98%
|
19.2%
|
15.2%
|
ROA (Net income/ Total Assets)
|
-
|
18.8%
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
5,335
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
0.8700
|
1.070
|
1.770
|
-
|
1.590
|
1.640
|
1.700
|
Cash Flow per Share
2 |
0.0800
|
-0.0100
|
0.2800
|
-
|
0.0700
|
0.0600
|
0.1700
|
Capex
|
111
|
256
|
500
|
-
|
-
|
-
|
-
|
Capex / Sales
|
6.77%
|
7.69%
|
14.29%
|
-
|
-
|
-
|
-
|
Announcement Date
|
07/04/20
|
26/02/21
|
07/04/22
|
19/04/23
|
15/04/24
|
-
|
-
|
Last Close Price
7.01
CNY Average target price
12
CNY Spread / Average Target +71.18% Consensus |
1st Jan change
|
Capi.
|
---|
| -3.97% | 4.14B | | +9.12% | 34.7B | | +18.62% | 8.18B | | +4.91% | 7.52B | | +38.58% | 4.2B | | +16.41% | 3.8B | | +6.97% | 3.48B | | -8.33% | 2.77B | | -28.89% | 2.36B | | -28.75% | 2.34B |
Testing & Measuring Equipment
|